GSK insists it best owner for Human Genome

Wednesday, April 25, 2012 - 08:40 in Paleontology & Archaeology

LONDON (Reuters) - Drugmaker GlaxoSmithKline said on Wednesday its $2.6 billion bid for long-time partner Human Genome Sciences was "full and fair" and it was the only obvious owner for the U.S. biotechnology firm.

Read the whole article on Reuters:Science

More from Reuters:Science

Related

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net